INDEGENE LIMITED Share Price

NSE: INDGN

₹ 495.00

+₹6.50 (1.33%)

Last updated 24 Jul, 2026, 15:29 IST

INDEGENE LIMITED Share Price Today

As of 25 Jul 2026, INDEGENE LIMITED share price is ₹495.00. The stock opened at ₹487.00, compared to its previous close of ₹488.50. During today's trading session, INDEGENE LIMITED share price moved in the range of ₹486.10 to ₹495.00, with an average price of ₹490.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹414.00 and a high of ₹596.80. On the performance front, INDEGENE LIMITED share price has increased by 3.87% over the last six months and is down 11.50% on a year-on-year basis.

₹486.10

1.33% up today

₹495.00

1D LOW

1D HIGH

Latest Earning

Op Profit TrendDown by 21.97% QoQ

Latest Earning

Net Profit TrendDown by 22.55% QoQ

Latest Earning

Revenue TrendUp by 5.48% QoQ

Stock Performance

OutperformingBeat Nifty by 7.7 % in last 6 month

Shareholding Pattern

DIIDII decreased stake by 3.83%

Shareholding Pattern

FIIFII decreased stake by 3.43%

INDEGENE LIMITED Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹4,45,264-₹54,736 (-10.95%)

3 Year

₹4,75,185-₹24,815 (-4.96%)

5 Year

₹4,75,185-₹24,815 (-4.96%)

₹390.80₹586.20

Circuit Low

Circuit High

₹414.00₹596.80

52-Week Low

52-Week High

Circuit

₹390.80

₹586.20

52-week

₹414.00

₹596.80

Mkt Cap Cr

11,769.80

P/E

26.05

P/B

3.33

ROE

13.94%

D/E

0.02

ROCE

17.11%

Div. Yield

0.52%

EPS(TTM)

8.83

Turnover

0.55

EV/EBITDA

15.23

Net Margin

17.36%

Op. Margin

26.74%

ROA

11.22%

Quick Ratio

0.00

Curr. Ratio

2.79

Mkt Cap Cr

11,769.80

P/E

26.05

P/B

3.33

ROE

13.94%

D/E

0.02

ROCE

17.11%

Div. Yield

0.52%

EPS(TTM)

8.83

Turnover

0.55

EV/EBITDA

15.23

Net Margin

17.36%

Op. Margin

26.74%

ROA

11.22%

Quick Ratio

0.00

Curr. Ratio

2.79

Based on fundamentals, this stock's

Performance

Very Poor

Indegene has not beaten FD return of 7%

Valuation

Fairly Valued

Indegene appears to be fairly valued compared to its peers

Earnings

Neutral

Indegene earnings growth is positive

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Apollo Hospitals	1,27,682.00	63.76	13.48	20.48%	0.32	17.27%	692.92	0.23%	0.70	103.81
Max Healthcare	1,05,470.00	64.89	8.71	14.33%	0.08	13.72%	10.47	0.21%	0.28	7.37
Fortis Healthcare	71,260.50	57.58	6.06	11.31%	0.22	13.36%	6.50	0.13%	0.16	3.05
Aster DM Healthcare	68,387.10	160.11	14.93	8.48%	0.31	10.10%	53.53	0.23%	0.46	5.20
Narayana Hrudayalaya	40,457.30	50.20	8.92	17.76%	0.76	11.42%	127.10	0.23%	0.85	24.77
Global Health	36,944.30	66.67	9.33	14.05%	0.06	15.26%	149.24	0.04%	0.77	18.46
KRISHNA INST OF MED SCI L	32,838.20	135.74	8.76	10.74%	0.63	7.99%	93.54	0.00%	0.46	6.52
Dr. Lal Path Labs	28,275.50	43.61	8.78	21.78%	0.07	27.45%	8.90	1.56%	1.01	30.45
Poly Medicure	16,538.80	51.57	5.32	10.37%	0.08	12.71%	301.18	0.21%	0.53	33.15
Syngene International	16,265.80	49.65	3.25	7.78%	0.05	9.52%	3.34	0.32%	0.67	7.58

INDEGENE LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹3,510.50	₹2,839.30	₹2,589.60	₹2,306.10
Other Income	₹72.00	₹107.20	₹76.30	₹58.00
Total Revenue	₹3,582.50	₹2,946.50	₹2,665.90	₹2,364.10
Total Expenses	₹3,037.20	₹2,407.20	₹2,209.70	₹2,001.10
Profit Before Tax	₹525.00	₹539.30	₹458.60	₹363.00
Tax	₹123.90	₹132.60	₹121.90	₹96.90
Profit After Tax	₹401.10	₹406.70	₹336.70	₹266.10
EPS - Basic	₹16.72	₹17.15	₹15.19	₹12.03
EPS - Diluted	₹16.62	₹17.02	₹15.07	₹11.97

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹525.00	₹539.30	₹458.60	₹363.00
Income before WC changes	₹652.20	₹577.80	₹536.80	₹454.40
Change in Assets	-₹19.60	-₹47.70	₹1.10	-₹174.60
Change in Liabilities	₹165.80	₹71.80	₹94.70	-₹41.40
Change in WC	₹146.20	₹24.10	₹95.80	-₹216.00
Cash flow from Operations	₹650.80	₹441.90	₹507.70	₹130.20
Cash flow from Investing	-₹512.40	-₹682.70	-₹327.20	-₹893.30
Cash flow from Financing	-₹82.60	₹287.50	-₹66.20	₹333.10
Total Cash Flow	₹55.80	₹46.70	₹114.30	-₹430.00
Cash (Start of the year)	₹241.00	₹188.60	₹73.60	₹506.30
Cash (End of the year)	₹300.80	₹241.00	₹188.60	₹73.60

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹2,001.90	₹795.90	₹754.80	₹755.20
Current Assets	₹2,618.40	₹2,530.00	₹1,790.80	₹1,448.70
Total Assets	₹4,620.30	₹3,325.90	₹2,545.60	₹2,203.90
Current Liabilities	₹1,086.20	₹564.50	₹610.90	₹489.10
Net Current Asset	₹1,532.20	₹1,965.50	₹1,179.90	₹959.60
Non-Current Liabilities	₹395.40	₹145.80	₹505.60	₹651.00
Equity Capital	₹3,138.70	₹2,615.60	₹1,429.10	₹1,063.80
Total Equity & Liabilities	₹4,620.30	₹3,325.90	₹2,545.60	₹2,203.90

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹1,220.60	₹1,093.60	₹1,045.60	₹1,005.70
Other Income	₹78.30	₹90.40	₹50.30	₹36.80
Total Revenue	₹1,298.90	₹1,184.00	₹1,095.90	₹1,042.50
Total Expenses	₹1,017.50	₹945.50	₹915.30	₹865.90
Profit Before Tax	₹281.40	₹238.50	₹180.60	₹176.60
Tax	₹69.50	₹57.20	₹42.70	₹46.40
Profit After Tax	₹211.90	₹181.30	₹137.90	₹130.20
EPS - Basic	₹8.83	₹7.64	₹6.22	₹5.89
EPS - Diluted	₹8.78	₹7.59	₹6.17	₹5.86

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹281.40	₹238.50	₹180.60	₹176.60
Income before WC changes	₹265.60	₹198.20	₹183.10	₹209.40
Change in Assets	₹122.20	₹9.30	-₹3.00	-₹107.00
Change in Liabilities	₹5.70	-₹7.90	₹45.40	₹21.30
Change in WC	₹127.90	₹1.40	₹42.40	-₹85.70
Cash flow from Operations	₹345.60	₹129.00	₹176.20	₹81.90
Cash flow from Investing	-₹272.10	-₹824.70	-₹187.70	-₹47.90
Cash flow from Financing	-₹62.60	₹717.30	-₹15.80	-₹16.90
Total Cash Flow	₹10.90	₹21.60	-₹27.30	₹17.10
Cash (Start of the year)	₹35.20	₹13.20	₹41.80	₹27.80
Cash (End of the year)	₹48.50	₹35.20	₹13.20	₹41.80

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹1,207.00	₹931.70	₹469.30	₹334.80
Current Assets	₹1,274.90	₹1,218.00	₹751.00	₹702.90
Total Assets	₹2,481.90	₹2,149.70	₹1,220.30	₹1,037.70
Current Liabilities	₹273.80	₹189.50	₹198.10	₹169.40
Net Current Asset	₹1,001.10	₹1,028.50	₹552.90	₹533.50
Non-Current Liabilities	₹127.60	₹72.00	₹68.40	₹73.00
Equity Capital	₹2,080.50	₹1,888.20	₹953.80	₹795.30
Total Equity & Liabilities	₹2,481.90	₹2,149.70	₹1,220.30	₹1,037.70

* All values are in INR Crore

Qty

Bid

Ask

Qty

Bid Total: 0

Ask Total: 0

Buy orders: 0%

Sell orders: 0%

30 levels of bid & ask depth

Supply & Demand Zones

Bearish

Neutral

Bullish

Neutral

by SEBI experts available for this stock

Earn more using advisory

by SEBI experts

Expert Pick

EXPPICK

Stop-loss

Entry price

Target

Indicator

Value

Verdict

RSI (14)

41.3

Neutral

ATR (14)

13.09

Neutral

STOCH(9,6)

34.3

Neutral

STOCH RSI (14)

39.02

Neutral

ADX(9)

26.97

Bearish

UO(9)

42.52

Neutral

ROC(12)

0.26

Bullish

WillR(14)

-68.25

Neutral

Period

Simple value

Exponential vaue

498.74

497.4

10D

504.5

501.25

20D

505.43

505.41

50D

512.84

507.77

100D

496.56

504.69

About INDEGENE LIMITED

ISIN

INE065X01017

Sector Market Cap

₹ 11,769.8 Cr

Indegene Limited is an India-based tech-native, life sciences commercialization company. The Company provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. Its segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Brand Activation, and Others. The Enterprise Commercial Solutions business unit caters to the digital marketing operations of life sciences companies. The Enterprise Medical Solutions consolidates large-scale regulatory and medical operations for life sciences companies. The Brand Activation segment offers promotion of biopharmaceutical products and medical devices to HCPs for life sciences companies across channels. It provides customized marketing campaigns through a comprehensive portfolio of proprietary program offerings. Others mainly consist of consultancy and clinical business.

INDEGENE LIMITED Financial Highlights

Revenue: INDEGENE LIMITED reported revenue of ₹3,582.50 crore in FY26 vs ₹2,946.50 crore in FY25. It showed an increase of 21.58% on a yearly basis.
Operating Profit: INDEGENE LIMITED reported an operating profit of ₹525.00 crore in FY26 vs ₹539.30 crore in FY25. It showed a decrease of 2.65% on a year-on-year basis.
Net Profit: INDEGENE LIMITED reported a net profit of ₹401.10 crore in FY26 vs ₹406.70 crore in FY25. It showed a decrease of 1.38% on a yearly basis.

INDEGENE LIMITED Quarterly Result Highlights

INDEGENE LIMITED reported revenue of ₹1,014.20 crore in Mar 2026, compared with ₹961.50 crore in Dec 2025, representing an increase of 5.48% on a quarter-on-quarter (QoQ) basis.
INDEGENE LIMITED reported an operating profit of ₹105.10 crore in Mar 2026, compared with ₹134.70 crore in Dec 2025, representing a decrease of 21.97% on a quarter-on-quarter (QoQ) basis.
INDEGENE LIMITED reported a profit of ₹79.70 crore in Mar 2026, compared with ₹102.90 crore in Dec 2025, reflecting a decrease of 22.55% on a QoQ basis.
The earnings per share (EPS) of INDEGENE LIMITED stood at ₹16.72 during Mar 2026.